SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-104182
Filing Date
2021-08-12
Accepted
2021-08-12 16:19:24
Documents
70
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q eyeg-20210630x10q.htm   iXBRL 10-Q 1432476
2 EXHIBIT 10.1 eyeg-20210630xex10d1.htm EX-10.1 142799
3 EXHIBIT 31.1 eyeg-20210630xex31d1.htm EX-31.1 7879
4 EXHIBIT 31.2 eyeg-20210630xex31d2.htm EX-31.2 7734
5 EXHIBIT 32.1 eyeg-20210630xex32d1.htm EX-32.1 5172
6 EXHIBIT 32.2 eyeg-20210630xex32d2.htm EX-32.2 4926
  Complete submission text file 0001104659-21-104182.txt   6026327

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA eyeg-20210630.xsd EX-101.SCH 47140
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eyeg-20210630_cal.xml EX-101.CAL 45403
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eyeg-20210630_def.xml EX-101.DEF 189201
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyeg-20210630_lab.xml EX-101.LAB 386167
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyeg-20210630_pre.xml EX-101.PRE 334851
12 EXTRACTED XBRL INSTANCE DOCUMENT eyeg-20210630x10q_htm.xml XML 897886
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36672 | Film No.: 211167848
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences